"Medicaid matters to children," conference told

30 January 2006

The USA's leading children's health care leaders gathered at a meeting this month to begin building a coalition safeguarding Medicaid and improving quality measurement standards. the Children's Hospital of Philadelphia, along with the National Association of Children's Hospitals, joined forces to create an alliance advocating for quality improvement measures to strengthen Medicaid and improve the state of pediatric practice.

80% of recipients are children

"Medicaid has changed dramatically over the past 20 to 30 years," stated Steven Altschuler, president and chief executive of The Children's Hospital of Philadelphia. "The fear is that the government will run out of money, that Medicaid will go bankrupt. This is a crisis. Medicaid is a safety net for a large segment of our population - and especially for children. 80% of Medicaid recipients are children - yet children represent only 20% of Medicaid utilization. As Medicaid funding is reduced, children bear the brunt of those cuts," Dr Altschuler added.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight